Although CHST4 is not a gene that is specifically expressed in MPM and is limited to cases in which a definitive diagnosis has been obtained via biopsy or other means, CHST4 may be involved in tumor immunity to MPM and can be used to predict therapeutic efficacy and prognosis. The gene discussed is CHST4; the disease is neoplasm.